Plain-English translation of NCT04689152 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new treatment called for patients with advanced alcoholic liver cirrhosis. The treatment uses stem cells harvested from your own bone marrow and injects them directly into your liver through a blood vessel to see if they can help repair liver damage. Researchers will follow you for five years to measure how well this treatment works compared to standard care alone.
Alcoholic cirrhosis causes severe scarring and liver damage that current treatments cannot reverse. This medication is being tested to see if stem cells can help regenerate liver tissue and improve how well the liver works.
You likely qualify if…
You likely don't qualify if…
If you are randomly selected to receive the treatment, doctors will extract bone marrow from your hip bone, process it to isolate stem cells, and then inject those cells directly into your liver through a catheter placed in a blood vessel. The control group will receive the best standard supportive care for cirrhosis. All participants will have regular follow-up visits over 5 years to check liver function through blood tests, imaging, and clinical evaluations.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
South Korea